drugset / Trial / NCT00109941

Opioid Growth Factor in Treating Patients With Advanced Pancreatic Cancer That Cannot Be Removed By Surgery

NCT00109941 ↗

Phase 2 Completed 25 enrolled Milton S. Hershey Medical Center
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Opioid growth factor may stop the growth of pancreatic cancer by blocking blood flow to the tumor. PURPOSE: This phase II trial is studying how well opioid growth factor works in treating patients with advanced pancreatic cancer that cannot be removed by surgery.

Timeline

Start
2003-10
Primary completion
2007-09
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Subject metenkefalin Peptide 250 ug/kg Intravenous